I've been a business reporter for a while. I've covered Wall Street, venture capital and now private equity. I'm always looking for a scoop or something to talk about. I'm the eternal optimist and am still waiting for the Chicago Cubs to win the World Series. Yes, I believe.
KKR said Aug. 1 that it acquired Salesforce Tower in Atlanta. KKR said it made the acquisition together with Banyan Street Capital in a joint venture valued at $205 million. Salesforce Tower is a 631,808 square foot, 34 story, Class A office tower located in Atlanta’s Buckhead submarket.
3 min read · 01 August 2019
2 min read · 31 July 2019
Aurora nears $1.5 bln target on Fund VI; Carlyle switches to C-corp; Thoma Bravo buys J.D. Power
2 min read · 31 July 2019
Carlyle Group is winding down a $4 billion energy credit business after the exit of its two co-heads, Bloomberg reported. The departures of David Albert and Rahul Culas triggered a key man event on Carlyle Energy Mezzanine Opportunities Fund II, the story said. The unit’s remaining team will discontinue investing from the $2.8 billion pool, Bloomberg said.
1 min read · 31 July 2019
Arsenal Capital Partners has acquired Caprion Biosciences from GHO Capital Partners LLP. Financial terms weren’t announced. Caprion is a specialized laboratory service business serving pharma and biotech companies.
3 min read · 31 July 2019
Welsh, Carson, Anderson & Stowe and Walgreens are investing in Shields Health Solutions. Financial terms weren’t announced. Shields is a specialty pharmacy integrator and care provider.
4 min read · 31 July 2019
Lightricks said July 31 that it raised $135 million in Series C funding led by Goldman Sachs Private Capital Investing. Insight Partners and ClalTech participated in the round. Lightricks creates photo and video editing apps.
3 min read · 31 July 2019
Thoma Bravo said July 30 that it agreed to buy J.D. Power. Financial terms weren’t announced. J.D. Power provides data analytics and consumer intelligence.
3 min read · 31 July 2019
Clayton, Dubilier & Rice said July 30 that it completed the sale of Tranzact to Willis Towers Watson for $1.3 billion.
2 min read · 31 July 2019
Alizé Pharma 3 said July 31 that it raised 67 million euros ($75 million) in a Series A round led by LSP. Novo Ventures, Kurma Partners, Orbimed, Pontifax, Partners Innovation Fund and Innobio 2 (managed by Bpifrance) participated in the round. Existing shareholders Sham Innovation Santé/Turenne Capital, Crédit Agricole Création and TAB Consulting also took part. Alizé Pharma 3, of France, develops therapeutic peptides for rare endocrine and metabolic diseases.
7 min read · 31 July 2019
